To investigate accommodative microfluctuations (AMFs) and visual function in short tear break-up time (BUT)-type dry eye (DE) and non-DE subjects.
This prospective comparative study included 48 volunteers with DE symptoms (mean age 34.8 ± 5.5 years, age range 25–42 years) and 73 without DE symptoms (mean age 30.6 ± 4.7 years, age range 25–42 years). The eyes were divided into two groups: (1) DE group with DE symptoms and BUT ≤ 5 s and (2) non-DE group without DE symptoms and BUT > 5 s. We excluded eyes with Schirmer score ≤ 5 mm and positive keratoconjunctival epithelial damage. Tear evaluation, AMF, and functional visual acuity (VA) examinations were performed. AMF parameters included total high-frequency component (HFC), HFC with low accommodation for the task of staring into the distance (HFC1), and HFC with high accommodation for deskwork (HFC2). Functional VA parameters included starting VA, functional VA, visual maintenance ratio, and blink frequency.
A total of 33 and 34 eyes were categorized in the DE and non-DE groups, respectively. Mean blink frequency and HFC1 values were significantly higher in the DE group than they were in the non-DE group.
Citation: Kaido M, Kawashima M, Shigeno Y, Yamada Y, Tsubota K (2017) Relation of accommodative microfluctuation with dry eye symptoms in short tear break-up time dry eye. PLoS ONE 12(9): e0184296. https://doi.org/10.1371/journal.pone.0184296
Editor: Deepak Shukla, University of Illinois at Chicago, UNITED STATES
Received: May 11, 2017; Accepted: August 21, 2017; Published: September 8, 2017
Copyright: © 2017 Kaido et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: Provision of facilities and transport of equipment were supported by Santen Pharmaceutical Co., Ltd, Osaka. The funder provided support in the form of salary for one author [YY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the ‘author contributions’ section.
Competing interests: Kowa Co., Ltd. Japan provided a monetary grant for research unrelated to the current study to the Department of Ophthalmology of Keio University School of Medicine. Drs Kazuo Tsubota and Minako Kaido hold patent rights for the method and apparatus used for the measurement of functional visual acuity (US patent no: 7470026). The other authors have no affiliation with any corporation. Yoshiaki Yamada is an employee of Santen Pharmaceutical Co., Ltd., Japan, while Kazuo Tsubota is a consultant and has received research funds unrelated to this study from Santen Pharmaceutical Co., Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
The International Dry Eye Workshop (DEWS) specifies two major classes of dry eye (DE) disease . The first is the aqueous-deficient DE characterized by lacrimal tear secretion failure, which causes ocular surface damage while the other class is an evaporative DE involving decreased tear film stability, known as short tear break-up time (BUT) DE. Short BUT DE is characterized by DE symptoms and tear film instability, despite little or no ocular surface damage . This type of DE has been reported to be associated with frequent and prolonged visual display terminal (VDT) exposure and contact lens usage. The prevalence of short BUT DE has increased in recent decades owing to a highly technological and information-oriented society with increased use of related visual aids [3–6].
DE is associated with various symptoms including burning, itching, redness, pain, and ocular fatigue. The presence of ocular surface damage understandably induces DE symptoms. However, patients with short BUT DE showing little or no ocular surface damage experience similar severe DE symptoms as well as aqueous tear deficient DE with corneal epithelial damage [7,8]. In addition, patients with short BUT DE exhibit equivocal symptoms such as ocular fatigue, discomfort, and dryness .
Furthermore, there have been cases of individuals with decreased tear stability without DE symptoms. Based on this observation, we hypothesized that the instability in the tear film may not be the sole cause of DE symptoms. As mentioned above, one of the typical symptoms of short BUT DE is ocular fatigue, which is widespread and associated with accommodation . Therefore, we hypothesized further that DE symptoms may be provoked by situations that stress the accommodative system, in addition to the instability of the tear film. Therefore, in this study, we investigated accommodative microfluctuations (AMFs) and visual function in subjects with and without DE symptoms.
We enrolled 48 volunteers with DE symptoms (25 men and 23 women, mean age 34.8 ± 5.5 years) and 73 without DE symptoms (50 men and 23 women, mean age 30.6 ± 4.7 years) both with age ranges from 25–42 years (S1 Table). All volunteers agreed to answer the study questionnaires by e-mail and then undergo the ophthalmic examinations at a later date at the Shinanozaka Clinic. To avoid any bias associated with age-dependent variations in accommodative functions, we recruited subjects who were 42 years old or younger. We excluded subjects with a history of ocular trauma or ophthalmic surgery occurring within 6 months, ophthalmic diseases including abnormality of the nasolacrimal drainage apparatus except for DE, decimal visual acuity (VA) of less than 0.6, daily contact lens usage, or usage of an ophthalmic solution prescribed by a doctor.
We assigned eyes with a BUT ≤ 5 s in volunteers with DE symptoms to the DE group, and eyes with a BUT > 5 s in the volunteers without DE symptoms to the non-DE group. In addition, we excluded eyes with Schirmer test ≤ 5 s, corneal staining score ≥ 3 pts, or both from the study. When both eyes were eligible for the study, only the eye with a lower BUT value in the DE group and higher BUT value in the non-DE group was studied.
This research followed the Tenets of the Declaration of Helsinki. We obtained written informed consent from all subjects after providing an explanation of the study procedures and possible consequences. We obtained approval for the examination procedures and study protocol from the Ethics Committee of the Institutional Review Board of the Shinanozaka Clinic Tokyo, Japan.
We administered a DE questionnaire widely used in Japan, which included 12 questions about the diagnostic symptoms of DE disease . Possible patient answers to questions to describe their symptoms included “constantly” (3 pts), “often” (2 pts), “sometimes” (1 pt), and “never” (0 pts). Subjects who responded to more than one of the 12 questions with “constantly” or “often” were considered to exhibit subjective DE symptoms. In contrast, subjects who responded to all the 12 questions with “sometimes” or “never” were considered devoid of subjective DE symptoms. Information on age, gender, smoking (current or not), and duration of VDT use was also obtained.
The DE specialist (MK) performed the eye examinations, including conjunctival and corneal vital staining with lissamine green and fluorescein, BUT measurement, tear meniscus height (TMH) measurement, Schirmer test without topical anesthesia, and slit-lamp assessment of lid margin. The tear stability was assessed using the standard BUT measurement. Keratoconjunctival epithelial damage was evaluated after the BUT measurement. The conjunctival sac was instilled with preservative-free 1% lissamine green and 1% sodium fluorescein (2 μL each, separately) using a micropipette. The overall epithelial damage was scored on a scale of 0–9 pts . We also assessed patients for possible eyelid margin abnormalities including vascular engorgement of the lid margin, displacement of the mucocutaneous junction, lid margin irregularity, and plugging. TMH was assessed using a graticule millimeter scale in the ocular eyepiece (Carl Zeiss Meditec, AG, Jena, Germany) at the last stage of the slit-lamp observation because the tear meniscus is precisely visible after the instillation of the staining fluid . Tear quantity was evaluated by performing the Schirmer test following all other examinations, using a sterilized Schirmer strip (Whatman No.41, Showa, Tokyo), only when it was necessary to screen the eyes under the categories of the DE and non-DE groups.
Functional VA measurement system
We performed continuous VA testing during a 60-s period under natural blinking, using the functional VA measurement system (Kowa, Aichi, Japan). The outcome parameters included starting VA, functional VA, visual maintenance ratio, and blink frequency [5,12]. Starting VA was defined as the uncorrected VA, as measured by the Functional VA Measurement System. Functional VA was defined as the average of all visual acuity values measured over time. Visual maintenance ratio was defined as the functional VA divided by the starting VA . The blink frequency was automatically recorded using the functional VA measurement device. We asked the patients to describe the orientation of automatically presented Landolt rings by manipulating a joystick.
AMF analysis system
We performed the AMF test using a dynamic auto-refractometer (AA-2TM, NIDEK, Nagoya, Japan) (Fig 1A). Fig 1B shows the measurement system of the AA-2TM. We presented the target on an open field refractometer, and based on the refraction at the far distance, the targets were set from 0.5 to -3.0 diopter of the objective refraction in steps of 0.5 diopters (i.e., eight steps total). We instructed the patients to maintain a clear gaze at the target at each step, and then the refractive error, the range of accommodation, and AMF were measured. Based on the AMF values, we calculated the power spectrum of the high-frequency component (HFC) using Fast Fourier Transformation as the frequency of HFC appearance to convert the values to the common logarithm and summed up values between 1.0 and 2.25 Hz [14,15]. The graph (frequency of kinetic [Fk]-reaction-map) appears in spectral colors that represent the values of the frequency of HFC appearance (Fig 1C and 1D).
(A) Dynamic auto-refractometer (AA-2TM) device. (B) Measurement system: accommodative microfluctuations are measured while focusing on an out-of-focus image at each predetermined distance. (C) Normal pattern of frequency of kinetic reaction map: the graph appears in green and green-yellow-red bars with low and high accommodation, respectively, that represents low HFC1 and relatively low HFC2 values. (D) Accommodative excess pattern of frequency of kinetic reaction map: the graph appears in red bars with low and high accommodation that represents high HFC1and HFC2 values, respectively.
We categorized the results of the power spectrum of the HFC base on two parameters including HFC1 and HFC2 denoting those with low accommodation (between 0.0–0.75 diopter accommodation constriction) for the task of staring into the distance and those with high accommodation (between -1.0 and -3.0 diopters) for deskwork, respectively. The total HFC was defined as the summation of the power spectrum of HFC with an accommodation between 0.75 and -3.0 diopters.
The evaluation parameters measured using the auto-refractometer were the refraction at a far distance and range of accommodation gazing at the target loading between 0.75 and -3.0 diopters, as well as the power spectra of HFC1, HFC2, and total HFC.
We used the Student t-test to analyze the DE symptoms and parameters as well as functional VA and accommodative parameters of the DE and non-DE groups. We used the statistical package for the social sciences (SPSS) software version 17.0J for Windows (SPSS Inc., Chicago, Illinois, USA) for statistical analysis. We considered a p < 0.05 as statistically significant.
Tear function assessment
The overall tear function results are shown in Table 1; however, the Schirmer test was eventually performed in 90 and 119 eyes in the subjects with and without DE symptoms, respectively in order to screen them to the DE and non-DE groups. A total of 80 (83.3%) of the 96 eyes (48 subjects) with DE symptoms, fulfilled at least one positive item of a BUT ≤ 5 seconds, Schirmer test ≤ 5 mm, and vital staining score ≥ 3 points, and were subsequently diagnosed as definite or probable DEs according to the Japanese DE criteria . For the 146 eyes of 73 subjects without DE symptoms, BUT > 5 seconds and Schirmer test > 5 mm were observed in 83 (56.8%) and 81 (68.1%) eyes. Overall, only 31.5% exhibited all normal tear functions.
Of the 48 subjects with DE symptoms, we assigned 33 eyes (33 subjects) to the DE group while we assigned 34 eyes (34 subjects) out of the 73 subjects without DE symptoms to the non-DE group. There were 5 and 7 (15.27 and 20.6%) current smokers the DE and non-DE groups, respectively (p > 0.05) and the mean duration of VDT use was 7.2 ± 3.9 and 6.2 ± 3.8 hours, respectively (p > 0.05). Table 2 shows the profile of tear functions for each group. The mean BUT and TMH values of the DE group were significantly lower than those of the non-DE group were (p < 0.05). Lid margin abnormalities, including vascular engorgement at lid margin, displacement of mucocutaneous junction, and lid margin irregularity, were not observed in subjects in any of the groups, except for the presence of plugging of the meibomian orifices observed in 5 and 2 (15.2 and 5.9%) subjects in the DE and non-DE groups, respectively.
Table 3 shows the prevalence of positive DE symptoms more than “sometimes” in the DE and non-DE groups. Fig 2 shows the frequency scores of DE symptoms for each group. Ocular fatigue showed the highest prevalence and severity of symptoms in the short BUT DE group.
Functional VA parameters
Fig 3 shows the results of the functional VA parameters for each group. The mean logarithm of the minimum angle of resolution (logMAR) of the starting VA, functional VA, and mean visual maintenance ratio did not show significant differences between the DE and non-DE groups (p > 0.05). The mean blink frequency was significantly lower in the DE than it was in the non-DE group(p < 0.05).
Refractive and accommodative parameters
The mean refractive values were -0.25 ± 0.65 and -0.25 ± 0.99 diopters and the mean range of accommodation was 1.79 ± 0.40 and 1.63 ± 0.39 diopters in the DE and non-DE groups, respectively. We did not observe significant differences between the groups (p > 0.05).
Fig 4 shows the mean values of the power spectra of HFC1, HFC2, and total HFC for each group. The mean HFC1 values were significantly higher (p < 0.05) and the mean total HFC values tended to be higher (p = 0.06) in the DE group than they were in the non-DE group. In contrast, the mean HFC2 did not show any significant differences between the groups (p > 0.05).
High-frequency component (HFC) 1, between 0.0–0.75 diopter with low accommodation for staring into the distance task; HFC2, between -1.0 and -3.0 diopters with high accommodation for desk work; and total HFC, between 0.75 and -3.0 diopters.
An evaluation of tear secretion and tear film stability is important in DE diagnosis. The Schirmer and BUT tests are commonly used to assess DE disease. However, subjective DE symptoms do not accurately correspond to the clinical signs measured using these tests [17–20]. Hua et al. reported a discrepancy between symptoms and clinical signs in 42% of patients . They specified that 55% had some DE signs regardless of negative DE symptoms. Interestingly, we obtained even higher discrepancy; the subjects without DE symptoms showed a decreased BUT value or a decreased Schirmer test value in approximately 70% of cases examined. The differences in results between this and the previous study may be attributable to differences in the populations of the subjects and assessment of DE disease.
Considering the subjects with DE symptoms, 80.2 and 27.1% showed a decrease in BUT and Schirmer test values, respectively while none had positive corneal damage, indicating that most of the subjects exhibited short BUT type DE. It is noteworthy that one of the major causes of decreased tear film stability is meibomian gland dysfunction [21–23]. Lin et al. reported that 61.7% of subjects with symptomatic DE had an anatomic abnormality of the meibomian gland . In contrast, some reports have suggested that decreased mucin expression may play a role in the dysfunction of ocular surface wettability and tear film stability [25,26]. The Japanese survey of DE prevalence in VDT workers (Osaka Study) showed that a high proportion of office workers with prolonged VDT use exhibited short BUT DE and had a low mucin concentration in their tears [27,28]. Our results showed that meibomian gland dysfunction was not observed in any of the cases in this study. Therefore, this result may support the theory of the dysfunction of ocular surface wettability and tear film stability being critical to the development of short BUT DE in young individuals without presbyopia. Typical DE symptoms in subjects with short BUT DE include ocular fatigue, dry eye sensation, eye itching and sensitivity to bright light, and their prevalence was 97.0, 72.7, 76.5, and 60.6%, respectively, as previously reported [2,8]. Our assessment of functional VA parameters revealed that the outcomes of blink frequency were significantly higher in the short BUT DE group than in the normal BUT non-DE group. Furthermore, there were no significant differences in functional VA and visual maintenance ratio. We previously reported visual impairment in patients with short BUT DE, using functional VA measurements [29,30]. The different outcomes in this study are possibly attributable to the tear film being normalized by frequent blinking, leading to stable VAs in the subsequent changes. Specifically, the VA and blinking affect each other during sequential visual performances. Accordingly, tear instability may have had little effect on the functional VA and visual maintenance ratio in this study.
Considering the possible factors that determine symptomatology, recent articles have pointed out that changes in sensory receptors and the influence of the central nervous system have a role in determining the presence or absence of symptoms in the presentation of DE disease [31–35]. Attention has been directed to alterations in tear film dynamics, temperature and osmolar changes, which alter nerve signaling resulting in pain.
In contrast, we focused our attention on the stress to the accommodative system in determining the factors that lead to the development of DE symptoms. We reported previously that DE symptoms diminished, and HFC1 and functional VA improved after DE treatment in the short BUT DE patients with severe symptoms . It suggests that tear film instability might be associated with deterioration of functional VA, AMF and DE symptoms. We compared AMFs and visual function between short BUT DE and non-DE subjects in this study. As supported to the previous study, the mean HFC1 value was significantly higher, and the total HFC value tended to be higher in the short BUT DE group than they were in the normal BUT non-DE group. Kajita et al. suggested that ocular fatigue is related to HFC1, which induces fluctuation with low accommodation during the process of staring at a distance . In agreement with this suggestion, we obtained high HFC1 values, which may be related to DE symptoms in subjects with short BUT DE. Regarding the accommodative response, the common assumption is that focusing on a target from a far to a near distance and holding a near vision induce accommodative stress. However, our results showed high HFC1 rather than HFC2 values in short BUT DE. Alteration of tear film thickness due to an irregular tear film on the ocular surface may cause tiny refractive errors, leading to defocusing of images even with distance vision and thereby resulting in high HFC1 values. In fact, the deterioration of optical quality in patients with DE is detected by the objective wavefront aberration methods [38,39]. We initially supposed that image defocus due to tearing instability directly represents visual impairment based on the decreased functional VA value. In addition, we supposed that the decrease in visual function might induce AMF from ocular or periocular stress, or both. However, visual function and AMF appear to be factors induced by image defocus due to unstable tear film (Fig 5), based on the results showing that partial correspondence between the accommodative and functional VA parameters was observed in subjects with short BUT DE.
There are a few limitations to this study, which are worth mentioning. First, we did not determine the low-frequency component (LFC) values, which were unmeasurable with the instruments used in this study. Furthermore, no consensus has been reached on the role of AMF, and this is still under discussion. While the LFC is thought to cause the optical fluctuation in the crystalline lens for focusing an out-of-focus image , a consensus on the role of HFC has not been established. Although a correlation with the arterial pulse has been observed in the function of HFC [41,42], it is still necessary to determine how the cardiovascular system compensates for the appearance of HFC in short BUT DE. Another limitation is that the subject recruitment may have been biased. The subjects enrolled in this study were volunteers who did not particularly require eye checkups from specialists and did not use ophthalmic solutions prescribed by a doctor. Therefore, the subjects assigned to the DE group might not be typical short BUT DE cases. Furthermore, we did not assess the details of the tear film break such as the tear break-up patterns and areas on the cornea, which might affect the outcomes. Therefore, further studies investigating the relationship between the details of tear break-up and symptoms, the visual function or accommodative responses are required.
In conclusion, we demonstrated the possible relationship of AMF and visual function to DE symptoms in short BUT DE. Determining the accommodative response may be beneficial for evaluating DE symptoms. This is a new concept, which suggests that the accommodative system may be involved in the development of DE symptoms in short BUT DE. Further studies should be conducted to determine whether DE treatments aimed at the stabilization of tear film would provide symptomatic relief in DE.
The authors thank Biostatistical Research Co., Tokyo, Japan for their assistance in data management.
- 1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Claassification Report. Ocul Surf 2017; 15:276–283. Review pmid:28736335
- 2. Toda I, Fujishima H, Tsubota K. Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh) 1993;71:347–352.
- 3. Uchino M, Nishiwaki Y, Michikawa T, Shirakawa K, Kuwahara E, Yamada M, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology 2011;118:2361–2367. pmid:21889799
- 4. Yamamoto Y, Yokoi N, Higashihara H, Inagaki K, Sonomura Y, Komuro A, et al. [Clinical characteristics of short tear film breakup time (BUT) -type dry eye]. Nihon Ganka Gakkai Zasshi 2012;116:1137–1143 [Article in Japanese]. pmid:23379203
- 5. Kaido M, Uchino M, Yokoi N, Uchino Y, Dogru M, kawashima M, et al. Dry-eye screening by using a functional visual acuity measurement system: the Osaka study. Invest Ophthalmol Vis Sci 2014;55:3275–3281. pmid:24801509
- 6. Kaido M, Kawashima M, Yokoi N, Fukui M, Ichihashi Y, Kato H, et al. Advanced dry eye screening for visual display terminal workers using functional visual acuity measurement: The Moriguchi Study. Br J Ophthalmol 2015; 99(11):1488–92. pmid:25883086
- 7. Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 1995;102:302–309. pmid:7862418
- 8. Yokoi N, Uchino M, Uchino Y, Dogru M, Kawashima M, Komuro A, et al. Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. Am J Ophthalmol 2014;159(4):748–54. pmid:25555800
- 9. Owens DA, Wolf-Kelly K. Near work, visual fatigue, and variations of oculomotor tonus. Invest Ophthalmol Vis Sci 1987;28:743–749. pmid:3557879
- 10. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10–14. pmid:4183019
- 11. Ibrahim OM, Dogru M, Ward SK, Matsumoto Y, Wakamatsu TH, Ishida K, et al. The efficacy, sensitivity, and specificity of strip meniscometry in conjunction with tear function tests in the assessment of tear meniscus. Invest Ophthalmol Vis Sci 2011;52:2194–198. pmid:21178139
- 12. Kaido M, Dogru M, Ishida R, Tsubota K. Concept of functional visual acuity and its applications. Cornea 2007;26:S29–S35 pmid:17881912
- 13. Kaido M, Dogru M, Yamada M, Sotozono C, Kinoshita S, Shimazaki J, et al. Functional visual acuity in Stevens-Johnson syndrome. Am J Ophthalmol 2006;142:917–922. pmid:17157576
- 14. Campbell FW, Westheimer G, Robson JG. Significance of fluctuations of accommodation. J Opt Soc Am. 1958;48:669. pmid:13564334
- 15. Campbell FW, Robson JG, Westheimer G. Fluctuations of accommodation under steady viewing conditions. J Physiol 1959;145:579–594. pmid:13642323
- 16. Shimazaki J. Definition and diagnosis of dry eye 2006 [in Japanese]. Atarashii Ganka (Journal of the Eye) 2007;24:181–184.
- 17. Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 997;104:1395–1401.
- 18. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762–770. pmid:15502475
- 19. Hua R, Yao K, Hu Y, Chen Ll. Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population-based analysis. BMJ Open 2014;4:e005296. pmid:25168038
- 20. Schmidl D, Witkowska KJ, Kaya S, Baar C, Faatz H, Nepp J, et al. The association between subjective and objective parameters for the assessment of dry-eye syndrome. Invest Ophthalmol Vis Sci 2015;56:1467–1472. pmid:25650419
- 21. Foulks G, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003;1:107–126. pmid:17075643
- 22. Bron AJ, Tiffany JM. The contribution of Meibomian disease to dry eye. Ocul Surf 2004;2:149–164. pmid:17216085
- 23. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78:347–360. pmid:15106912
- 24. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WH. Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology. 2003;110:1096–1101. pmid:12799232
- 25. Watanabe H. Significance of mucin on the ocular surface. Cornea. 2002;21:S17–S22. pmid:11995804
- 26. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45 supple 2:S203–S210.
- 27. Uchino Y, Uchino M, Yokoi N, Dogru M, Kawashima M, Okada N. Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study. JAMA Ophthalmol 2014;132:985–992. pmid:24903353
- 28. Shimazaki-Den S, Dogru M, Higa K, Shimazaki J. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea 2013;32:1211–1218. pmid:23846406
- 29. Kaido M, Uchino M, Kojima T, Dogru M, Tsubota K. Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye. J Ocul Pharmacol Ther 2013;29:595–603. pmid:23537148
- 30. Kaido M, Ishida R, Dogru M, Tsubota K. Visual function changes after punctal occlusion with the treatment of short BUT type of dry eye. Cornea 2012;31:1009–1013. pmid:22357386
- 31. Keech A, Senchyna M, Jones. Impact of time between collection and collection method on human tear fluid osmolarity. Curr Eye Res 2013;38:428–436. pmid:23402632
- 32. Parra A, Gonzalez-Gonzalez O, Gallar J, Belmonte C. Tear fluid hyperosmolality increases nerve impulse activity of cold thermoreceptor endings of the cornea. Pain 2014;155:1481–1491. pmid:24785271
- 33. Belmonte C, Acosta MC, Merayo-Lloves J, Gallar J. What Causes Eye Pain? Curr Ophthalmol Rep 2015;3:111–121. pmid:26000205
- 34. Liu H, Begley C, Chen M, Bradley A, Bonanno J, McNamura NA, et al. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 2009;50:3671–3679. pmid:19324847
- 35. Kaido M, Kawashima M, Ishida R, Tsubota K. Relationship of corneal pain sensitivity with dry eye symptoms in dry eye with short tear break-up time. Invest Ophthalmol Vis Sci. 2016;57(3):914–9. pmid:26943154
- 36. Kaido M, Kawashima M, Ishida R, Tsubota K. Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations Clin Ophthalmol. 2017;11:861–869. pmid:28503063
- 37. Kajita M, Ono M, Suzuki S, Kato K. Accommodative microfluctuation in asthenopia caused by accommodative spasm. Fukushima J Med Sci 2001;47:13–20. pmid:11764414
- 38. Montes-Mico R, Alio JL, Charman WN. Dynamic changes in the tear film in dry eyes. Invest Ophthalmol Vis Sci 2005;46:1615–1619. pmid:15851559
- 39. Koh S, Maeda N, Horohara Y, Mihashi T, Bessho K, Hori Y, et al. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci. 2008;49:133–138. pmid:18172085
- 40. Charman WN, Heron G. Fluctuations in accommodation: a review. Ophthalmic Physiol Opt 1988;8:153–164. pmid:3062549
- 41. Winn B, Pugh JR, Gilmartin B, Owens H. Arterial pulse modulates steady-state ocular accommodation. Curr Eye Res 1990;9:971–975. pmid:2276274
- 42. Collins M, Davis B, Wood J. Microfluctuations of steady-state accommodation and the cardiopulmonary system. Vision Res 1995;35:2491–2502. pmid:8594816